24 mar 1977 ano - Tamoxifen Approved

Descrição:

Approved initially by the FDA for treatment of metastatic breast cancer, it then expanded to be used for reduce risks of recurrence in recovering patients, reduce risk of contralateral breast cancer in women with breast cancer, and to lower chance of breast cancer in women at high risk.

Adicionado na linha do tempo:

Data: